Granules India Share Price Target 2026 — Analyst Forecast, Catalysts and Key Risks

Thu Apr 23 2026

The Granules India share price target 2026 stands at Rs 587-687 as per analyst consensus — implying 21-41% upside from the current CMP of Rs 487. Investors tracking the Granules India share price target 2026 need to understand the complete picture — the specific growth catalysts, FY27 earnings timeline, risks, and the bull vs bear case that will determine whether Granules India (GRANULES) achieves or misses this 12-month target. This article covers every dimension of the Granules India share price target 2026 thesis — catalysts, risks, scenarios, analyst ratings, and key levels — updated April 2026.

Click Here — Get Free SEBI-registered Research on Granules India on Univest.

Table of Contents

Granules India Share Price Overview — April 2026

Company	Granules India
NSE Symbol	GRANULES
Sector	Pharma / API Finished Dosage Form / US Export
CMP April 2026	Rs 487
52-Week High	Rs 727
52-Week Low	Rs 387
Market Cap	Rs 11,800 Cr
Trailing P/E	22x
Dividend FY26	Rs 3
Promoter Holding	42.2%
FII Holding	14.8%
12M Analyst Target	Rs 587-687
Upside from CMP	21-41%

Data from NSE/BSE and publicly available research. April 2026. Verify before investing.

Track live Granules India price, FII/DII flows and analyst targets on the Univest Screener.

What Is Granules India?

Get Free Analyst Research on Granules India — Tap Here.

Granules India (NSE: GRANULES) manufactures bulk APIs and FDF (Finished Dosage Forms) — paracetamol, metformin, ibuprofen for US and European markets. FY26 revenue Rs 4,200 crore recovering post FY25 FDA headwinds. EBITDA margin expanding from 18% to 21%+.

Budget 2026-27 Impact on Pharma

Budget 2026-27’s API PLI supports Granules’ bulk drug scale-up. US market demand recovery for OTC molecules benefits core product basket.

Granules India share price target 2026 — Short, 12-Month and Long-Term Horizons

Horizon	Target	Key Assumption
Short-Term 3-6 Months	Rs 587	Q4 FY26 results beat and technical recovery
12-Month Consensus	Rs 587-687	FY27 earnings delivery and macro normalisation
Long-Term FY27-28	20-30% above 12M	Full earnings recovery and sector re-rating
Bear Case	Rs 387 zone	FY27 miss and extended FII selling

Compare Granules India with sector peers live on the Univest Screener.

5 Growth Catalysts Supporting the Granules India share price target 2026

1. India Pharma Sector — Structural Growth Tailwind

India’s Pharma sector is expanding at 12-18% annually — driven by rising incomes, urbanisation, government policy, and the India structural growth story. Granules India’s market position within this sector creates compounding runway that underpins the Granules India share price target 2026 consensus of Rs 587-687. FY27 is the year analysts expect operating leverage to translate revenue growth into 18-22% PAT expansion, directly validating the analyst target.

2. FY27 Earnings Recovery — Primary Re-Rating Catalyst

After FY26 headwinds from US tariff uncertainty, FII outflows, and sector-specific pressures, analyst consensus projects Granules India to deliver 15-20% PAT growth in FY27. Q4 FY26 results (April-May 2026) with positive FY27 guidance are the immediate trigger for re-rating toward the Granules India share price target 2026 consensus of Rs 587-687. Track Q4 results live on the Univest Screener.

3. Competitive Moat — Defensible Market Position Built Over Decades

Granules India holds a structural competitive moat in its Pharma segment — brand equity, distribution depth, technical capability, or customer relationships that take 10-15 years to replicate. This moat protects market share during competitive cycles and enables pricing power in upcycles — the structural argument for the premium valuation embedded in the Granules India share price target 2026 of Rs 587-687.

4. RBI Rate Cut Cycle — Reducing Cost of Capital

India’s RBI rate cut cycle commenced in 2026 reduces Granules India’s borrowing costs and stimulates end-customer demand for Pharma products. Lower interest rates improve EBITDA-to-PAT conversion — directly expanding EPS and supporting the Granules India share price target 2026 of Rs 587-687 by making the earnings multiple more justifiable.

5. Budget 2026-27 Policy Alignment and Government Capex Support

Union Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption incentives create a positive policy backdrop for Granules India’s Pharma business. Regulatory clarity and government spending certainty reduce operating risk — improving earnings visibility that directly supports the Granules India share price target 2026 bull case.

Download the Univest iOS App or Android App for live Granules India alerts and SEBI-registered research.

5 Risks That Could Impact the Granules India share price target 2026

1. US Tariff and Global Macro Headwinds

The 26% US reciprocal tariff (April 2026) created FII outflow pressure across Indian equities including Granules India. Prolonged US-India trade tension would reduce FY27 estimates by 5-10% — the key downside risk to the Granules India share price target 2026 consensus of Rs 587-687.

2. Valuation at 22x Requires Consistent Execution

At 22x trailing P/E, Granules India is priced for sustained growth. Any Q4 FY26 miss or FY27 guidance cut triggers multiple compression — the most immediate risk to the Granules India share price target 2026. The Rs 387 52-week low zone is the key support and stop-loss reference.

3. Competition Intensifying in Pharma

Domestic and global competitors are investing aggressively in Granules India’s Pharma market. Pricing pressure or market share erosion compresses revenue growth visibility and reduces the multiple supporting the Granules India share price target 2026.

4. Input Cost and Supply Chain Volatility

Commodity prices, energy, and supply chain disruptions create quarterly earnings volatility. Any cost increase that cannot be passed through compresses EBITDA below analyst estimates — creating downside risk to the Granules India share price target 2026 of Rs 587-687.

5. FII Selling Risk — 14.8% Institutional Holding

With 14.8% FII ownership, Granules India is exposed to global risk-off events triggering institutional selling disconnected from fundamentals. FII exits temporarily suppress the stock below levels justified by the Granules India share price target 2026 analyst consensus of Rs 587-687.

Granules India Bull Case vs Bear Case — Granules India share price target 2026

Scenario	Price Target	Probability	Trigger
Bull Case	687	Medium	FY27 earnings beat, FII re-entry, sector re-rating
Base Case	Rs 587-687	High	FY27 in-line earnings, stable macro
Bear Case	Rs 387 zone	Low	FY27 guidance cut, prolonged FII selling

Granules India Share Price Reference Table

NSE Symbol	GRANULES
CMP	Rs 487
52-Week High	Rs 727
52-Week Low	Rs 387
Market Cap	Rs 11,800 Cr
P/E	22x
Promoter	42.2%
FII	14.8%
Dividend FY26	Rs 3
Short-Term Target	Rs 587
12M Target	Rs 587-687
Upside	21-41%

Sources: NSE/BSE, Screener.in, publicly available analyst research. April 2026.

Analyst Ratings and Granules India share price target 2026

Brokerage	Rating	Target	Key View
MOFSL	Buy	Rs 584	FY27 earnings recovery and Pharma sector leadership
YES Securities	Buy	Rs 594	Quality execution — accumulate at support levels
Kotak Institutional	Add	Rs 560	Monitor Q4 FY26 guidance — maintain position
JM Financial	Neutral	Consensus	Await Q4 FY26 result clarity before adding

Subscribe to Univest Pro for SEBI-registered entry, target and stop-loss on Granules India.

How to Invest in Granules India — 5 Steps

Step 1: Research on the Univest Screener

Search GRANULES on univest.in/screeners. Review quarterly results, FII/DII trend, promoter holding, and analyst consensus on the Granules India share price target 2026.

Step 2: Identify Entry Level

Granules India at Rs 487 has key support near Rs 387. Plan entry near support with stop-loss 8-10% below entry. First resistance toward the Granules India share price target 2026 recovery is Rs 587.

Step 3: Monitor Q4 FY26 Results

Q4 FY26 results (April-May 2026) are the near-term trigger. A beat with positive FY27 guidance triggers re-rating toward 687 — the bull case for the Granules India share price target 2026.

Step 4: Position Sizing

Allocate maximum 3-5% of your portfolio to any single stock. Never invest more than you can hold for 2+ years through volatility.

Step 5: Track on the Univest App

Download the Univest iOS App or Android App for live price alerts and SEBI-registered research aligned with the Granules India share price target 2026.

Conclusion — Granules India share price target 2026

Granules India (GRANULES) at Rs 487 offers 21-41% potential upside to the 12-month Granules India share price target 2026 consensus of Rs 587-687. The bull case to 687 requires FY27 earnings delivery and macro normalisation. The bear case (Rs 387 zone) materialises only on significant earnings disappointment. For long-term investors with a 2-3 year horizon, Granules India at current levels presents a monitored entry opportunity. For more Granules India share price target 2026 analysis and peer comparisons, visit Univest Blogs.

Disclaimer: Investment in the share market is subject to market risks. This article is for educational and informational purposes only and does not constitute investment advice. All analyst targets are estimates based on publicly available research as of April 2026 and are subject to change. Verify all data on NSE/BSE before investing. Consult a SEBI-registered financial advisor before making any investment decisions.

Frequently Asked Questions — Granules India share price target 2026

Q: What is Granules India share price target for 2026?

The 12-month Granules India share price target 2026 analyst consensus is Rs 587-687 — implying 21-41% upside from CMP Rs 487. Bull case: 687. Bear case: Rs 387 zone. Track the live Granules India share price target 2026 on the Univest Screener. These are analyst estimates, not guaranteed returns.

Q: Is Granules India a good buy at Rs 487?

This article does not constitute investment advice. At Rs 487, Granules India offers 21-41% upside to the Granules India share price target 2026 consensus of Rs 587-687. Suitability depends on your risk tolerance and investment horizon. Consult a SEBI-registered financial advisor before investing.

Q: What is Granules India 52-week high and low?

Granules India’s 52-week high is Rs 727 and 52-week low is Rs 387. At the current CMP of Rs 487, the stock has corrected from its 52-week high — creating recovery potential for investors aligned with the Granules India share price target 2026 thesis.

Q: What sector is Granules India (GRANULES) in?

Granules India operates in the Pharma / API Finished Dosage Form / US Export sector. India’s Pharma sector is growing structurally — driven by rising incomes, government policy, and India’s consumption expansion — underpinning the Granules India share price target 2026 bull case.

Q: What are the main risks for the Granules India share price target 2026 thesis?

Key risks: US tariff macro headwinds, valuation at 22x requiring consistent execution, competition in Pharma, input cost volatility, and FII selling pressure (14.8% holding). Monitor quarterly earnings closely.

Q: What is Granules India’s market cap?

Granules India has a market cap of Rs 11,800 Cr as of April 2026. At the Granules India share price target 2026 of Rs 587-687, the implied market cap would reflect 21-41% appreciation on the current base.

Q: What is Granules India dividend for FY26?

Granules India’s FY26 dividend is Rs 3. Track dividend announcements on NSE or the Univest Screener. Dividend yield adds to the total return alongside the Granules India share price target 2026 capital appreciation potential.

Q: How to buy Granules India shares?

Buy Granules India (GRANULES) through any SEBI-registered broker on NSE. Research first on the Univest Screener, set a price alert at the Rs 387 support zone, and download the Univest App for SEBI-registered research on the Granules India share price target 2026.